Literature DB >> 32424471

Combination of non-thermal plasma and subsequent antibiotic treatment for biofilm re-development prevention.

Jaroslav Julák1, Eva Vaňková2, Markéta Válková2, Petra Kašparová2, Jan Masák2, Vladimír Scholtz3.   

Abstract

The influence of non-thermal plasma (NTP) treatment on the prevention of antibiotic resistance of microbial biofilms was studied. Staphylococcus epidermidis and Escherichia coli bacteria and a yeast Candida albicans, grown on the surface of Ti-6Al-4V alloy used in the manufacture of prosthetic implants, were employed. Their biofilms were exposed to NTP produced by DC cometary discharge and subsequently treated with antibiotics commonly used for the treatment of infections caused by them: erythromycin (ERY), polymyxin B (PMB), or amphotericin B (AMB), respectively. All biofilms displayed significant reduction of their metabolic activity after NTP exposure, the most sensitive was S. epidermidis. The subsequent action of antibiotics caused significant decrease in the metabolic activity of S. epidermidis and E. coli, but not C. albicans, although the area covered by biofilm decreased in all cases. The combined effect of NTP with antibiotics was thus proved to be a promising strategy in bacterial pathogen treatment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32424471     DOI: 10.1007/s12223-020-00796-3

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  2 in total

1.  Non-thermal plasma causes Pseudomonas aeruginosa biofilm release to planktonic form and inhibits production of Las-B elastase, protease and pyocyanin.

Authors:  Petra Kašparová; Eva Vaňková; Martina Paldrychová; Alžběta Svobodová; Romana Hadravová; Irena Jarošová Kolouchová; Jan Masák; Vladimir Scholtz
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

2.  Inactivation of Staphylococcus aureus and Escherichia coli Biofilms by Air-Based Atmospheric-Pressure DBD Plasma.

Authors:  S Khosravi; S Jafari; H Zamani; M Nilkar
Journal:  Appl Biochem Biotechnol       Date:  2021-08-04       Impact factor: 2.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.